Source: Eur Respir J, 54 (1) 1901121; 10.1183/13993003.01121-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
David W. Connell, Morven Wilkie. Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes?. Eur Respir J, 54 (1) 1901121; 10.1183/13993003.01121-2019

Member's Comments

No comment yet.

Related content which might interest you: Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018 Year: 2019 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Pulmonary diseases caused by non-tuberculous mycobacteria Source: Eur Respir Mon 2012; 58: 25-37 Year: 2012 Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species Source: Eur Respir J 2013; 41: 1230-1232 Year: 2013 Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013 Do CT findings of Mycobacterium abscessus infection in patients with Cystic Fibrosis predict outcome? Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017 Mycobacterium xenopi pulmonary disease in Croatia Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Residential bathroom is a candidate for source of pulmonary mycobacterium avium complex infection Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006 Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD) Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 The new “Hesitation Blues”: initiating Mycobacterium avium complex lung disease therapy Source: Eur Respir J , 49 (3) 1700110; DOI: 10.1183/13993003.00110-2017 Year: 2017 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005